Newman-Tancredi A[au] - Search Results

Year	Number of Results
1991	1
1992	2
1993	1
1995	5
1996	3
1997	8
1998	11
1999	7
2000	15
2001	11
2002	10
2003	3
2004	3
2005	10
2006	7
2007	16
2008	7
2009	10
2010	8
2011	8
2012	3
2013	2
2014	6
2015	6
2016	5
2017	4
2018	8
2019	11
2020	10
2021	15
2022	11

1

The contrasting landscape of drug discovery in neuropsychopharmacology. A conversation with Adrian Newman-Tancredi.

Newman-Tancredi A, Zimmer L. Newman-Tancredi A, et al. Therapie. 2021 Mar-Apr;76(2):71-74. doi: 10.1016/j.therap.2020.12.004. Epub 2020 Dec 5. Therapie. 2021. PMID: 33436275

2

International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.

Barnes NM, Ahern GP, Becamel C, Bockaert J, Camilleri M, Chaumont-Dubel S, Claeysen S, Cunningham KA, Fone KC, Gershon M, Di Giovanni G, Goodfellow NM, Halberstadt AL, Hartley RM, Hassaine G, Herrick-Davis K, Hovius R, Lacivita E, Lambe EK, Leopoldo M, Levy FO, Lummis SCR, Marin P, Maroteaux L, McCreary AC, Nelson DL, Neumaier JF, Newman-Tancredi A, Nury H, Roberts A, Roth BL, Roumier A, Sanger GJ, Teitler M, Sharp T, Villalón CM, Vogel H, Watts SW, Hoyer D. Barnes NM, et al. Among authors: newman tancredi a. Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.

3

Perspectives for therapy of treatment-resistant depression.

Papp M, Cubala WJ, Swiecicki L, Newman-Tancredi A, Willner P. Papp M, et al. Among authors: newman tancredi a. Br J Pharmacol. 2022 Sep;179(17):4181-4200. doi: 10.1111/bph.15596. Epub 2021 Jul 29. Br J Pharmacol. 2022. PMID: 34128229 Review.

4

[¹⁸F]F13640, a 5-HT_1A Receptor Radiopharmaceutical Sensitive to Brain Serotonin Fluctuations.

Colom M, Vidal B, Fieux S, Redoute J, Costes N, Lavenne F, Mérida I, Irace Z, Iecker T, Bouillot C, Billard T, Newman-Tancredi A, Zimmer L. Colom M, et al. Among authors: newman tancredi a. Front Neurosci. 2021 Mar 8;15:622423. doi: 10.3389/fnins.2021.622423. eCollection 2021. Front Neurosci. 2021. PMID: 33762906 Free PMC article.

5

The 5-HT_1A receptor as a serotonergic target for neuroprotection in cerebral ischemia.

Aguiar RP, Newman-Tancredi A, Prickaerts J, Oliveira RMW. Aguiar RP, et al. Among authors: newman tancredi a. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jul 13;109:110210. doi: 10.1016/j.pnpbp.2020.110210. Epub 2020 Dec 14. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 33333136 Review.

6

Towards in vivo imaging of functionally active 5-HT_1A receptors in schizophrenia: concepts and challenges.

Razakarivony O, Newman-Tancredi A, Zimmer L. Razakarivony O, et al. Among authors: newman tancredi a. Transl Psychiatry. 2021 Jan 7;11(1):22. doi: 10.1038/s41398-020-01119-3. Transl Psychiatry. 2021. PMID: 33414418 Free PMC article. Review.

7

¹⁸F-F13640 PET imaging of functional receptors in humans.

Colom M, Costes N, Redouté J, Dailler F, Gobert F, Le Bars D, Billard T, Newman-Tancredi A, Zimmer L. Colom M, et al. Among authors: newman tancredi a. Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):220-221. doi: 10.1007/s00259-019-04473-7. Epub 2019 Aug 14. Eur J Nucl Med Mol Imaging. 2020. PMID: 31414208 No abstract available.

8

Identification of the 5-HT_1A serotonin receptor as a novel therapeutic target in a C. elegans model of Machado-Joseph disease.

Pereira-Sousa J, Ferreira-Lomba B, Bellver-Sanchis A, Vilasboas-Campos D, Fernandes JH, Costa MD, Varney MA, Newman-Tancredi A, Maciel P, Teixeira-Castro A. Pereira-Sousa J, et al. Among authors: newman tancredi a. Neurobiol Dis. 2021 May;152:105278. doi: 10.1016/j.nbd.2021.105278. Epub 2021 Jan 28. Neurobiol Dis. 2021. PMID: 33516872 Free article.

9

NLX-101, a cortical 5-HT_1A receptor biased agonist, reverses scopolamine-induced deficit in the delayed non-matching to position model of cognition.

Depoortere RY, Auclair AL, Newman-Tancredi A. Depoortere RY, et al. Among authors: newman tancredi a. Brain Res. 2021 Aug 15;1765:147493. doi: 10.1016/j.brainres.2021.147493. Epub 2021 Apr 20. Brain Res. 2021. PMID: 33887253

10

NLX-101, a highly selective 5-HT_1A receptor biased agonist, mediates antidepressant-like activity in rats via prefrontal cortex 5-HT_1A receptors.

Depoortère R, Auclair AL, Newman-Tancredi A. Depoortère R, et al. Among authors: newman tancredi a. Behav Brain Res. 2021 Mar 5;401:113082. doi: 10.1016/j.bbr.2020.113082. Epub 2020 Dec 25. Behav Brain Res. 2021. PMID: 33358917

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results